Physician profile
Sai Vemula
NPI 1568037372
$13,539.79
in general payments reported to CMS, 2019-2025
16 companies · $4,482 in 2025
The $4,482 reported for 2025 was more than what 96% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $9,057 · 2025: $4,482.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $9,035 · Food and Beverage: $4,315 · Education: $190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $9,035.09 |
| Food and Beverage | $4,314.71 |
| Education | $189.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $3,660.40 | 2024-2025 | Truelok, Physio-Stim |
| Stryker Corporation | $3,392.21 | 2024-2025 | Ortholoc 3di, Hoffmann, Prostep Mica |
| Paragon 28, INC. | $1,654.02 | 2024-2025 | Portfolio, Monkey Rings, R3flex |
| Medline Industries LP | $1,552.68 | 2024 | |
| Arthrex, INC. | $1,314.46 | 2025 | |
| Medshape, INC. | $962.09 | 2024 | Dynanail Hybrid, Dynanail, Dynanail Helix, Washer, 15 Mm |
| Seapearl East, INC | $268.16 | 2025 | |
| Medical Device Business Services, INC. | $189.99 | 2024 | |
| Kerecis Limited | $144.35 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Amgen INC. | $125.00 | 2024 | Krystexxa |
| Integra Lifesciences Corporation | $98.65 | 2024-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Abbvie INC. | $63.55 | 2024-2025 | |
| Paratek Pharmaceuticals, INC. | $35.39 | 2025 | Nuzyra |
| Organogenesis INC. | $31.14 | 2024 | |
| Ethicon US, LLC | $29.40 | 2024 | Stratafix |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $18.30 | 2025 | Collagenase Santyl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sai Vemula listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.